Jump to content

Timothy J. Ley: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
No edit summary
Tag: wikilinks removed
 
(10 intermediate revisions by 7 users not shown)
Line 9: Line 9:
}}
}}
{{DISPLAYTITLE:Timothy J. Ley}}
{{DISPLAYTITLE:Timothy J. Ley}}
'''Timothy J. Ley''' is an American hematologist and cancer biologist. He is the Lewis T. and Rosalind B. Apple Professor of Oncology in the Department of Medicine, and is chief of the Section of Stem Cell Biology in the Division of Oncology at [[Washington University in St. Louis]]. He is a member of the [[Alvin J. Siteman Cancer Center]].<ref>{{cite web | title = Timothy Ley, MD | url = http://www.siteman.wustl.edu/ResearcherProfile.aspx?id=1006&memid=88 | access-date = 6 August 2012}}</ref>
'''Timothy J. Ley''' is an American hematologist and cancer biologist. He is the Lewis T. and Rosalind B. Apple Professor of Oncology in the department of medicine, and is chief of the section of stem cell biology in the division of oncology at [[Washington University in St. Louis]]. He is a member of the [[Alvin J. Siteman Cancer Center]].<ref>{{cite web | title = Timothy Ley, MD | url = http://www.siteman.wustl.edu/ResearcherProfile.aspx?id=1006&memid=88 | access-date = 6 August 2012}}</ref>


Ley's research group focuses on the genetics and genomics of [[acute myeloid leukemia]] (AML). His lab studies the development of normal and leukemic blood cells. His work is focused on identifying the mutations and epigenetic events that are responsible for the initiation and progression of AML.<ref>[http://news.bbc.co.uk/2/hi/health/8184950.stm "Cancer gene complexity revealed."] "BBC News". 7 August 2009.</ref>
Ley's research group focuses on the genetics and genomics of [[acute myeloid leukemia]] (AML). His lab studies the development of normal and leukemic blood cells. His work is focused on identifying the mutations and epigenetic events that are responsible for the initiation and progression of AML.<ref>[http://news.bbc.co.uk/2/hi/health/8184950.stm "Cancer gene complexity revealed."] "BBC News". 7 August 2009.</ref>


Ley led the team that sequenced the first cancer genome (of an AML patient).<ref>[https://query.nytimes.com/gst/fullpage.html?res=9804E6D9123DF935A35752C1A96E9C8B63&sec=&spon=&pagewanted=2 "Experts Decode Cancer Patient's Genes, Seeking Treatment Clues."] ''New York Times''. 6 November 2008.</ref> He has gone on to develop projects that will use whole genome sequencing to help diagnose and treat patients with AML.<ref>[https://www.nytimes.com/2012/07/08/health/in-gene-sequencing-treatment-for-leukemia-glimpses-of-the-future.html?_r=3 "In Treatment for Leukemia, Glimpses of the Future."] "New York Times". 7 July 2012.</ref>
Ley led the team that sequenced the first cancer genome (of an AML patient).<ref name = "First Cancer Seq">{{cite journal |author=Timothy Ley |title=DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome |journal=Nature |volume=456 |issue=7218 |date=November 2008 |pmid= 18987736
| doi=10.1038/nature07485 |pmc=2603574|display-authors=etal |pages=66–72|bibcode=2008Natur.456...66L }}</ref><ref>[https://query.nytimes.com/gst/fullpage.html?res=9804E6D9123DF935A35752C1A96E9C8B63&sec=&spon=&pagewanted=2 "Experts Decode Cancer Patient's Genes, Seeking Treatment Clues."] ''New York Times''. 6 November 2008.</ref> He has gone on to develop projects that will use whole genome sequencing to help diagnose and treat patients with AML.<ref>[https://www.nytimes.com/2012/07/08/health/in-gene-sequencing-treatment-for-leukemia-glimpses-of-the-future.html?_r=3 "In Treatment for Leukemia, Glimpses of the Future."] "New York Times". 7 July 2012.</ref>


To better understand the role of many of the mutations discovered through whole genome sequencing of leukemias, he and his colleagues have constructed several mouse models of AML, which are very similar to human AML.<ref>[http://www.siteman.wustl.edu/internal.aspx?id=476 Siteman Cancer Center History]</ref> Dr. Ley's laboratory has also helped to define the roles of granzymes for the functions of cytotoxic and regulatory [[T cells]].<ref>[http://www.siteman.wustl.edu/ResearcherProfile.aspx?id=1006&memid=88 Siteman Cancer Center Profile]</ref>
To better understand the role of many of the mutations discovered through whole genome sequencing of leukemias, he and his colleagues have constructed several mouse models of AML, which are very similar to human AML.<ref>[http://www.siteman.wustl.edu/internal.aspx?id=476 Siteman Cancer Center History]</ref> Dr. Ley's laboratory has also helped to define the roles of granzymes for the functions of cytotoxic and regulatory [[T cells]].<ref>[http://www.siteman.wustl.edu/ResearcherProfile.aspx?id=1006&memid=88 Siteman Cancer Center Profile]</ref>


Ley grew up in [[Lakota, Iowa]]. He received his B.A. degree from [[Drake University]] in 1974, and his M.D. from [[Washington University School of Medicine]] in 1978. He did his internship and residency in Medicine at [[Massachusetts General Hospital]], was a Clinical Associate at the [[NHLBI]] (National Heart, Lung, and Blood Institute), a Hematology-Oncology Fellow at Washington University Medical Center, and a Senior Investigator at the NHLBI before moving to Washington University in 1986.
Ley grew up in [[Lakota, Iowa]]. He received his B.A. degree from [[Drake University]] in 1974, and his M.D. from [[Washington University School of Medicine]] in 1978. He did his internship and residency in Medicine at [[Massachusetts General Hospital]], was a clinical associate at the [[NHLBI]] (National Heart, Lung, and Blood Institute), a Hematology-Oncology Fellow at Washington University Medical Center, and a senior investigator at the NHLBI before moving to Washington University in 1986.


In 2015, Ley was appointed to the National Cancer Advisory Board <ref>[http://www.nasonline.org/news-and-multimedia/news/2019-nas-election.html News from the National Academy of Sciences]</ref> by President Obama.<ref>[https://obamawhitehouse.archives.gov/the-press-office/2015/06/19/president-obama-announces-more-key-administration-posts President Obama Announces More Key Administration Posts]</ref> Ley was the recipient of the [[Leopold Griffuel Prize]] <ref>[https://www.fondation-arc.org/50e-prix-fondation-arc-leopold-griffuel Leopold Griffuel Prize]</ref> for Basic Science in 2022.
In 2015, Ley was appointed to the National Cancer Advisory Board <ref>[http://www.nasonline.org/news-and-multimedia/news/2019-nas-election.html News from the National Academy of Sciences]</ref> by President Obama.<ref>[https://obamawhitehouse.archives.gov/the-press-office/2015/06/19/president-obama-announces-more-key-administration-posts President Obama Announces More Key Administration Posts]</ref> Ley was the recipient of the [[Leopold Griffuel Prize]]<ref>[https://www.fondation-arc.org/50e-prix-fondation-arc-leopold-griffuel Leopold Griffuel Prize]</ref> for Basic Science in 2022.


==Awards and honors==
==Awards and honors==
Line 42: Line 43:
*[http://news.bbc.co.uk/2/hi/health/8184950.stm "Cancer gene complexity revealed."] ''BBC News.'' 7 August 2009.
*[http://news.bbc.co.uk/2/hi/health/8184950.stm "Cancer gene complexity revealed."] ''BBC News.'' 7 August 2009.


{{authority control}}
{{DEFAULTSORT:Ley, Timothy}}
{{DEFAULTSORT:Ley, Timothy}}
[[Category:1953 births]]
[[Category:1953 births]]
[[Category:Living people]]
[[Category:Living people]]
[[Category:Cancer genomics]]
[[Category:Members of the National Academy of Medicine]]
[[Category:Fellows of the American Academy of Arts and Sciences]]
[[Category:Washington University in St. Louis fellows]]
[[Category:Washington University School of Medicine faculty]]
[[Category:Washington University School of Medicine alumni]]
[[Category:Drake University alumni]]

Latest revision as of 21:34, 9 February 2024

Timothy J. Ley, MD
Timothy J. Ley
Scientific career
InstitutionsWashington University School of Medicine

Timothy J. Ley is an American hematologist and cancer biologist. He is the Lewis T. and Rosalind B. Apple Professor of Oncology in the department of medicine, and is chief of the section of stem cell biology in the division of oncology at Washington University in St. Louis. He is a member of the Alvin J. Siteman Cancer Center.[1]

Ley's research group focuses on the genetics and genomics of acute myeloid leukemia (AML). His lab studies the development of normal and leukemic blood cells. His work is focused on identifying the mutations and epigenetic events that are responsible for the initiation and progression of AML.[2]

Ley led the team that sequenced the first cancer genome (of an AML patient).[3][4] He has gone on to develop projects that will use whole genome sequencing to help diagnose and treat patients with AML.[5]

To better understand the role of many of the mutations discovered through whole genome sequencing of leukemias, he and his colleagues have constructed several mouse models of AML, which are very similar to human AML.[6] Dr. Ley's laboratory has also helped to define the roles of granzymes for the functions of cytotoxic and regulatory T cells.[7]

Ley grew up in Lakota, Iowa. He received his B.A. degree from Drake University in 1974, and his M.D. from Washington University School of Medicine in 1978. He did his internship and residency in Medicine at Massachusetts General Hospital, was a clinical associate at the NHLBI (National Heart, Lung, and Blood Institute), a Hematology-Oncology Fellow at Washington University Medical Center, and a senior investigator at the NHLBI before moving to Washington University in 1986.

In 2015, Ley was appointed to the National Cancer Advisory Board [8] by President Obama.[9] Ley was the recipient of the Leopold Griffuel Prize[10] for Basic Science in 2022.

Awards and honors

[edit]

References

[edit]
  1. ^ "Timothy Ley, MD". Retrieved 6 August 2012.
  2. ^ "Cancer gene complexity revealed." "BBC News". 7 August 2009.
  3. ^ Timothy Ley; et al. (November 2008). "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome". Nature. 456 (7218): 66–72. Bibcode:2008Natur.456...66L. doi:10.1038/nature07485. PMC 2603574. PMID 18987736.
  4. ^ "Experts Decode Cancer Patient's Genes, Seeking Treatment Clues." New York Times. 6 November 2008.
  5. ^ "In Treatment for Leukemia, Glimpses of the Future." "New York Times". 7 July 2012.
  6. ^ Siteman Cancer Center History
  7. ^ Siteman Cancer Center Profile
  8. ^ News from the National Academy of Sciences
  9. ^ President Obama Announces More Key Administration Posts
  10. ^ Leopold Griffuel Prize
[edit]
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Timothy_J._Ley&oldid=1205526963"